Small-interference RNA-mediated knock-down of aldehyde oxidase 1 in 3T3-L1 cells impairs adipogenesis and adiponectin release

FEBS Letters

Volumn 582, Issue 19, 2008, Pages 2965-2972

  Weigert, Johanna ^a   Neumeier, Markus ^a   Bauer, Sabrina ^a   Mages, Wolfgang ^b   Schnitzbauer, Andreas A ^a   Obed, Aiman ^a   Gröschl, Benedikt ^a   Hartmann, Arndt ^a   Schäffler, Andreas ^a   Aslanidis, Charalampos ^a   Schölmerich, Jürgen ^a   Buechler, Christa ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Adipocytes; Adipose tissue; Peroxisome proliferator activated receptor agonist

Indexed keywords

ADIPONECTIN; ALDEHYDE OXIDASE 1; FENOFIBRATE; OXIDOREDUCTASE; SMALL INTERFERING RNA;

ADIPOCYTE; ADIPOGENESIS; ADULT; AGED; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LIPID STORAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SECRETION;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ADIPONECTIN; ALDEHYDE OXIDOREDUCTASES; ANIMALS; MICE; PROCETOFEN; RNA, SMALL INTERFERING; THIAZOLIDINEDIONES;

EID: 48749121995     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.07.034     Document Type: Article

References (40)

1. Johns D.G. Human liver aldehyde oxidase: differential inhibition of oxidation of charged and uncharged substrates. J. Clin. Invest. 46 (1967) 1492-1505
2. Kitamura S., Sugihara K., and Ohta S. Drug-metabolizing ability of molybdenum hydroxylases. Drug Metab. Pharmacokinet. 21 (2006) 83-98
3. Garattini E., Fratelli M., and Terao M. Mammalian aldehyde oxidases: genetics, evolution and biochemistry. Cell Mol. Life Sci. 65 (2008) 1019-1048
4. Knox W. The Quinine-oxidizing enzyme and liver aldehyde oxidase. J. Biol. Chem. 163 (1946) 699-711
5. Negre-Salvayre A., Coatrieux C., Ingueneau C., and Salvayre R. Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors. Br. J. Pharmacol. 153 (2008) 6-20
6. Kundu T.K., Hille R., Velayutham M., and Zweier J.L. Characterization of superoxide production from aldehyde oxidase: an important source of oxidants in biological tissues. Arch. Biochem. Biophys. 460 (2007) 113-121
7. Otteneder M.B., Knutson C.G., Daniels J.S., Hashim M., Crews B.C., Remmel R.P., Wang H., Rizzo C., and Marnett L.J. In vivo oxidative metabolism of a major peroxidation-derived DNA adduct, M1dG. Proc. Natl. Acad. Sci. USA 103 (2006) 6665-6669
8. Moriwaki Y., Yamamoto T., and Higashino K. Distribution and pathophysiologic role of molybdenum-containing enzymes. Histol. Histopathol. 12 (1997) 513-524
9. Conklin D., Prough R., and Bhatanagar A. Aldehyde metabolism in the cardiovascular system. Mol. Biosyst. 3 (2007) 136-150
10. Tirard J., Gout J., Lefrancois-Martinez A.M., Martinez A., Begeot M., and Naville D. A novel inhibitory protein in adipose tissue, the aldo-keto reductase AKR1B7: its role in adipogenesis. Endocrinology 148 (2007) 1996-2005
11. Miyauchi K., Masaki R., Taketani S., Yamamoto A., Akayama M., and Tashiro Y. Molecular cloning, sequencing, and expression of cDNA for rat liver microsomal aldehyde dehydrogenase. J. Biol. Chem. 266 (1991) 19536-19542
12. Demozay D., Rocchi S., Mas J.C., Grillo S., Pirola L., Chavey C., and Van Obberghen E. Fatty aldehyde dehydrogenase: potential role in oxidative stress protection and regulation of its gene expression by insulin. J. Biol. Chem. 279 (2004) 6261-6270
13. Schaffler A., Scholmerich J., and Buchler C. Mechanisms of disease: adipocytokines and visceral adipose tissue - emerging role in nonalcoholic fatty liver disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 2 (2005) 273-280
14. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., Hotta K., Shimomura I., Nakamura T., Miyaoka K., Kuriyama H., Nishida M., Yamashita S., Okubo K., Matsubara K., Muraguchi M., Ohmoto Y., Funahashi T., and Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257 (1999) 79-83
15. Subauste A.R., and Burant C.F. Role of FoxO1 in FFA-induced oxidative stress in adipocytes. Am. J. Physiol. Endocrinol. Metab. 293 (2007) E159-E164
16. Vohl M.C., Sladek R., Robitaille J., Gurd S., Marceau P., Richard D., Hudson T.J., and Tchernof A. A survey of genes differentially expressed in subcutaneous and visceral adipose tissue in men. Obes. Res. 12 (2004) 1217-1222
17. Schaffler A., Ehling A., Neumann E., Herfarth H., Paul G., Tarner I., Gay S., Buechler C., Scholmerich J., and Muller-Ladner U. Role of specificity protein-1, PPARgamma, and pituitary protein transcription factor-1 in transcriptional regulation of the murine CORS-26 promoter. Biochim. Biophys. Acta 1678 (2004) 150-156
18. Neumeier M., Weigert J., Schaffler A., Weiss T.S., Schmidl C., Buttner R., Bollheimer C., Aslanidis C., Scholmerich J., and Buechler C. Aldehyde oxidase 1 is highly abundant in hepatic steatosis and is downregulated by adiponectin and fenofibric acid in hepatocytes in vitro. Biochem. Biophys. Res. Commun. 350 (2006) 731-735
19. Kielar D., Dietmaier W., Langmann T., Aslanidis C., Probst M., Naruszewicz M., and Schmitz G. Rapid quantification of human ABCA1 mRNA in various cell types and tissues by real-time reverse transcription-PCR. Clin. Chem. 47 (2001) 2089-2097
20. Fox K.E., Fankell D.M., Erickson P.F., Majka S.M., Crossno Jr. J.T., and Klemm D.J. Depletion of cAMP-response element-binding protein/ATF1 inhibits adipogenic conversion of 3T3-L1 cells ectopically expressing CCAAT/enhancer-binding protein (C/EBP) alpha, C/EBP beta, or PPAR gamma 2. J. Biol. Chem. 281 (2006) 40341-40353
21. Srivastava R.A., Jahagirdar R., Azhar S., Sharma S., and Bisgaier C.L. Peroxisome proliferator-activated receptor-alpha selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice. Mol. Cell. Biochem. 285 (2006) 35-50
22. Cabrero A., Alegret M., Sanchez R.M., Adzet T., Laguna J.C., and Vazquez M. Bezafibrate reduces mRNA levels of adipocyte markers and increases fatty acid oxidation in primary culture of adipocytes. Diabetes 50 (2001) 1883-1890
23. Sharma A.M., and Staels B. Review: Peroxisome proliferator-activated receptor gamma and adipose tissue - understanding obesity-related changes in regulation of lipid and glucose metabolism. J. Clin. Endocrinol. Metab. 92 (2007) 386-395
24. Sugihara K., Kitamura S., Tatsumi K., Asahara T., and Dohi K. Differences in aldehyde oxidase activity in cytosolic preparations of human and monkey liver. Biochem. Mol. Biol. Int. 41 (1997) 1153-1160
25. Wright R.M., Riley M.G., Weigel L.K., Ginger L.A., Costantino D.A., and McManaman J.L. Activation of the human aldehyde oxidase (hAOX1) promoter by tandem cooperative Sp1/Sp3 binding sites: identification of complex architecture in the hAOX upstream DNA that includes a proximal promoter, distal activation sites, and a silencer element. DNA Cell Biol. 19 (2000) 459-474
26. Zhu Q., and Liao K. Differential expression of the adipocyte amino acid transporter is transactivated by SP1 and SP3 during the 3T3-L1 preadipocyte differentiation process. Biochem. Biophys. Res. Commun. 271 (2000) 100-106
27. Madsen L., Petersen R.K., and Kristiansen K. Regulation of adipocyte differentiation and function by polyunsaturated fatty acids. Biochim. Biophys. Acta 1740 (2005) 266-286
28. Diez J.J., and Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur. J. Endocrinol. 148 (2003) 293-300
29. Son C., Hosoda K., Matsuda J., Fujikura J., Yonemitsu S., Iwakura H., Masuzaki H., Ogawa Y., Hayashi T., Itoh H., Nishimura H., Inoue G., Yoshimasa Y., Yamori Y., and Nakao K. Up-regulation of uncoupling protein 3 gene expression by fatty acids and agonists for PPARs in L6 myotubes. Endocrinology 142 (2001) 4189-4194
30. Fukuen S., Iwaki M., Yasui A., Makishima M., Matsuda M., and Shimomura I. Sulfonylurea agents exhibit peroxisome proliferator-activated receptor gamma agonistic activity. J. Biol. Chem. 280 (2005) 23653-23659
31. Obach R.S., Huynh P., Allen M.C., and Beedham C. Human liver aldehyde oxidase: inhibition by 239 drugs. J. Clin. Pharmacol. 44 (2004) 7-19
32. Nakano S., Inada Y., Masuzaki H., Tanaka T., Yasue S., Ishii T., Arai N., Ebihara K., Hosoda K., Maruyama K., Yamazaki Y., Shibata N., and Nakao K. Bezafibrate regulates the expression and enzyme activity of 11beta-hydroxysteroid dehydrogenase type 1 in murine adipose tissue and 3T3-L1 adipocytes. Am. J. Physiol. Endocrinol. Metab. 292 (2007) E1213-E1222
33. Hiuge A., Tenenbaum A., Maeda N., Benderly M., Kumada M., Fisman E.Z., Tanne D., Matas Z., Hibuse T., Fujita K., Nishizawa H., Adler Y., Motro M., Kihara S., Shimomura I., Behar S., and Funahashi T. Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 635-641
34. Fridlyand L.E., and Philipson L.H. Reactive species and early manifestation of insulin resistance in type 2 diabetes. Diabetes Obes. Metab. 8 (2006) 136-145
35. Lechpammer S., Epperly M.W., Zhou S., Nie S., Glowacki J., and Greenberger J.S. Adipocyte differentiation in Sod2(-/-) and Sod2(+/+) murine bone marrow stromal cells is associated with low antioxidant pools. Exp. Hematol. 33 (2005) 1201-1208
36. Mercader J., Ribot J., Murano I., Felipe F., Cinti S., Bonet M.L., and Palou A. Remodeling of white adipose tissue after retinoic acid administration in mice. Endocrinology 147 (2006) 5325-5332
37. Huang D.Y., and Ichikawa Y. Two different enzymes are primarily responsible for retinoic acid synthesis in rabbit liver cytosol. Biochem. Biophys. Res. Commun. 205 (1994) 1278-1283
38. Soares A.F., Guichardant M., Cozzone D., Bernoud-Hubac N., Bouzaidi-Tiali N., Lagarde M., and Geloen A. Effects of oxidative stress on adiponectin secretion and lactate production in 3T3-L1 adipocytes. Free Radic. Biol. Med. 38 (2005) 882-889
39. Gunnarsson P.O., Andersson S.B., Sandberg A.A., and Ellman M. Accumulation of estramustine and estromustine in adipose tissue of rats and humans. Cancer Chemother. Pharmacol. 28 (1991) 361-364
40. Yoshinari K., Okino N., Sato T., Sugatani J., and Miwa M. Induction of detoxifying enzymes in rodent white adipose tissue by aryl hydrocarbon receptor agonists and antioxidants. Drug Metab. Dispos. 34 (2006) 1081-1089